Haass M, Skofitsch G
Life Sci. 1985 Dec 2;37(22):2085-90. doi: 10.1016/0024-3205(85)90580-6.
Recently it has been shown that calcitonin gene-related peptide (CGRP) and substance P (SP) are coexisting in central and peripheral nerve endings of sensory neurons. In the present study we compared the vasodepressor and plasma extravasating activity of CGRP with that of SP. Systemic administration of CGRP to pithed, vagotomized rats evoked a dose dependent, long lasting vasodilation accompanied by a parallel rise in heart rate. The tachycardic response to CGRP may indicate a direct positive chronotropic action on the heart since this effect could not be blocked by beta-adrenoceptor blockade. For any equimolar dose the hypotensive effect of CGRP was much larger than that of SP. Both, CGRP and SP, showed a more pronounced decrease in mean arterial blood pressure after elevation of basal blood pressure levels by constant infusion of either phenylephrine, arginine-vasopressin, or angiotensin II. After systemic administration in equimolar doses CGRP was much less effective in producing plasma extravasation than SP. In conclusion, at equimolar doses CGRP is 10 times more potent than SP in producing vasodilatation but it possesses less than a third of the potency of equimolar doses of SP in producing plasma extravasation.
最近研究表明,降钙素基因相关肽(CGRP)和P物质(SP)共存于感觉神经元的中枢和外周神经末梢。在本研究中,我们比较了CGRP与SP的血管舒张和血浆外渗活性。向去脑迷走神经切断的大鼠全身给药CGRP,可引起剂量依赖性、持久的血管舒张,并伴有心率平行升高。对CGRP的心动过速反应可能表明其对心脏有直接的正性变时作用,因为这种效应不能被β-肾上腺素能受体阻断所阻断。对于任何等摩尔剂量,CGRP的降压作用比SP大得多。在通过持续输注去氧肾上腺素、精氨酸加压素或血管紧张素II使基础血压水平升高后,CGRP和SP均显示平均动脉血压有更明显的下降。等摩尔剂量全身给药后,CGRP在产生血浆外渗方面比SP的效果差得多。总之,在等摩尔剂量下,CGRP在产生血管舒张方面比SP强10倍,但在产生血浆外渗方面其效力不到等摩尔剂量SP的三分之一。